HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
Zoledronic acid was initially used for bone metastases in various malignancies. However, it
is unknown whether hepatic arterial infusion chemotherapy combined with zoledronic acid can
improve overall survival of unresectable hepatocellular carcinoma.